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Case report Laparo-endoscopic single-site (LESS) radical 
nephrectomy with renal vein thrombectomy: initial 
report
RyanP Kopp1, Jonathan L Silberstein1 and Ithaar H Derweesh*1,2
Abstract
Background: By combining trocar sites and extraction incision, Laparo-endoscopic Single-site Surgery (LESS) may 
provide less morbidity than traditional laparoscopy. Concerns continue about LESS for locally advanced tumors. We 
present our experience with LESS-radical nephrectomy with renal vein thrombectomy (LESS-RN-RVT)
Case Presentation: Between 5-6/2009, 2 patients underwent LESS-RN-RVT (1 right-/1 left-side). Standard steps of 
multi-site laparoscopic radical nephrectomy were performed, including stapled renal vein thrombectomy and intact 
specimen extraction. Both cases were successfully completed by LESS without complications. Mean tumor size was 7.8 
cm, incision size 4.5 cm, operative time 152 min, EBL 100 ml, and hospital stay 2.5 days. Both patients had negative 
margins, and are alive at time of last follow-up. One did not require postoperative opiates.
Conclusions: LESS-RN-RVT is safe and feasible in selected patients with renal vein thrombi. Further accumulation of 
data and comparison to multiport laparoscopic technique are requisite.
Background
Since introduction of laparoscopic radical nephrectomy
(LRN) [1], the procedure has been adopted as standard of
care for a variety of indications [2-4], with equivalent out-
comes to open surgery and improvements in analgesic
requirement, recovery time, and cosmesis [5]. By consoli-
dating working trocar and extraction sites into a single
location, Laparo-endoscopic Single-site Surgery (LESS)
may further limit morbidity and enhance advantages
associated with traditional laparoscopy [6-8]. Questions
persist regarding appropriateness of LESS for locally
advanced renal tumors. Herein we describe two cases of
renal tumors with renal vein thrombus that underwent
LESS radical nephrectomy and renal vein thrombectomy
(LESS-RN-RVT).
Case Presentations
As part of an IRB-approved prospective single institu-
tional prospective evaluation of LESS for radical and par-
tial nephrectomy, in May and June 2009 two patients
presented with renal tumors and renal vein thrombi
(Table 1). Both patients underwent history, physical
examination, staging evaluation (chest/abdominal/pelvic
CT, liver function tests, bone scintigraphy if necessary)
and were offered LESS-RN-RVT.
Case 1
55-year-old female presented with right flank pain and
weight loss. CT scan demonstrated an 8.5-cm right lower
pole enhancing renal mass suspicious for renal cell carci-
noma (RCC) with renal vein thrombus. Metastatic
workup was negative.
Case 2
50-year-old female presented with right shoulder pain
and left flank pain. CT demonstrated a left 8.0-cm renal
mass with renal vein thrombus overlying the peri-aortic
region. Metastatic workup revealed osseous metastases
in the spine and left clavicle. (Figure 1) Cytoreductive
nephrectomy with thrombectomy was planned as part of
a multi-disciplinary approach involving systemic targeted
therapy with sunitinib (Sutent, Pfizer, NY) and radiation
therapy.
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Surgical Technique
The patient is placed in modified flank position (45° angle
r e l a t i v e  t o  b e d ,  k i d n e y  r e s t  u p ,  t a b l e  i n  f l e x ) .  A  p e r i -
umbilical incision is made to the rectus fascia. The peri-
toneum is entered at cranial most aspect of the incision,
that is, at the umbilical portubation with a 5 mm extra
long (150 mm length) Xcel trocar (Ethicon-Endosurgery,
Cincinnati, OH). Pneumoperitoneum to 15 mm Hg is
created through this port and a 5 mm zero degree 35 cm
long laparoscope (Stryker, Kalamazoo, MI) is inserted to
visualize the abdomen. A 5 mm non-shielded low profile
trocar, (65 mm length, Ethicon) is placed 1-1.5 cm caudal
and at the 4 o'clock position to the extra long trocar,
eventually functioning as the camera port. A 12 mm stan-
dard length (100 mm) Xcel trocar (Ethicon) is inserted 1.5
cm caudal to the 5 mm low profile port. The resulting
configuration has a triangular arrangement (Figure 2a). A
fourth 12 mm standard length Xcel trocar was the placed
1 cm cephalad to the umbilical protuberance, through
which liver or splenic retraction and control of the upper
pole and adrenal gland is achieved (Figure 2b). We mini-
mized the intracorporeal profile of the Xcel trocars, and
that in conjunction with the variety of trocar lengths
allowed us to stagger the external profiles in order to
minimize instrument clashing.
Trocars are adjusted to minimize intracorporeal length
and vary extracorporeal profile, allowing greater degree
of freedom and less restriction of motion by adjacent
instruments. Tissue dissection is largely performed with
standard extra long laparoscopic instruments (non-lock-
ing laparoscopic deBakey bowel forceps, right angle dis-
sector, Maryland dissector, endoshears) and 5 mm
harmonic ACE 36 cm curved shears (Ethicon). Flexible,
Table 1: Patient Demographics and Tumor Characteristics
Patient Age Sex Tumor size 
(cm)
On imaging
BMI Laterality Tumor 
location
15 5 F8 . 5 2 6 R i g h t L o w e r  p o l e
2 50 F 8.0 21 Left Upper/mid 
pole
Figure 1 Left renal tumor with renal vein thrombus.
Figure 2 (a) and (b) (a) LESS incision and trocar position for left 
radical nephrectomy and renal vein thrombectomy and (b) as 
part of the same incision a cephalad 12 mm trocar was subse-
quently added in each case to assist with further retraction.
 
 
 Kopp et al. BMC Urology 2010, 10:8
http://www.biomedcentral.com/1471-2490/10/8
Page 3 of 6
reticulating, bent or otherwise modified instrumentation
were not used. Utilization of extra-long instruments cre-
ates extracorporeal triangulation which compensates for
the intracorporeal triangulation afforded by spaced tro-
cars in multi-site laparoscopy. Furthermore, by utilizing
ports placed in a horizontal plane and performing tissue
dissection in a vertical plane and observing traction/
counter-traction surgical principles, instrument clashing
is further minimized. Following takedown of the white
line of Toldt, the 0 degree laparoscope is exchanged for a
5 mm, 45 cm, 30 degree laparoscope with a right angle
adaptor and inline camera head (Strkyer), further mini-
mizing instrument and camera clashing. On the right
side, the hepatocolic ligament was incised and the left
side the splenocolic and splenorenal ligaments are also
taken down to facilitate medial rotation of the large bowel
and exposure of the kidney, followed by ureteral identifi-
cation and ligation.
Exposure of the lower pole facilitates placement of ver-
tical traction to expose the hilum for meticulous dissec-
tion of renal artery and vein. An endo-paddle retractor
(Covidien), is used to assist in splenic or hepatic retrac-
tion or bowel/duodenal retraction placed when through
the most cephalad or caudad 12 mm Xcel Trocar, respec-
tively. Transition may be seen within the vein where the
thrombus terminates. On the right side, with a shorter
vein, dissection to the confluence at the inferior vena cava
ensures evaluation for an adequate margin prior to liga-
tion. Use of an atraumatic grasper assists to milk the
thrombus toward the kidney if necessary, and may aid in
defining thrombus margin. An Endopath ETS Flex 45
Endoscopic Articulating Linear Cutter with a white vas-
cular reload (Ethicon) is placed through the 12 mm port
and used to sequentially ligate renal artery followed by
the renal vein, distally to the thrombus (Figure 3). On the
right side the stapler is placed parallel to the vena cava at
the confluence of the renal vein and vena cava while con-
tinuing vertical traction on the kidney.
Adrenalectomy is also performed. On the right side,
upward traction on the liver is placed and the posterior
peritoneum is incised from the white line of Toldt later-
ally up to the inferior vena cava medially. Completion of
the upper pole dissection is carried out and Gerota's fas-
cia is opened is opened with the harmonic scalpel, fol-
lowed by dissection of the lateral and posterior aspects of
the inferior vena cava. The inferior adrenal arteries are
coagulated with the harmonic scalpel,, and the middle
adrenal vein is identified and then clipped with 5 mm The
5-mm Hem-o-Lok clips (Teleflex Medical, Research Tri-
angle Park, NC) and transected. On the left, following
transaction of the renal vein and thrombectomy, which
were distal to the confluence of renal vein, the renal adre-
nal gland was removed by a combination of dissection
with the harmonic scalpel and with staple ligation. A 15
mm bladeless Xcel trocar is exchanged for the caudal 12
mm port and a 15 mm Endo Catch bag (Covidien, Mans-
field, Massachusetts) is used to extract the specimen.
Hemostasis is confirmed prior to closure. Trocars are
removed and fascial defects are connected to allow speci-
men retrieval.
Results
LESS-RN-RVT was completed in both patients without
complications. Operative data is summarized in Table 2.
Operative times for patients 1 and 2 were 132 and 171
minutes, respectively. Estimated blood loss (EBL) was 100
ml in each case. Incision size was 4 cm for patient one
and 5 cm for patient 2 (Figure 4). Final pathology in
patient one was primary tumor size 8.0 cm, RCC, clear
cell type, Fuhrman grade 2, stage T3bNxMx, with nega-
tive margins. Final pathology for case 2 was primary
tumor size 7.6 cm, RCC, clear cell type, Fuhrman grade 3,
stage T3bNxM1, with negative margins (Figure 5). Patient
1 was maintained on tramadol without need for opiates.
Patient 2 was taking hydrocodone preoperatively for bone
pain, and required additional hydromorphone for 23
hours postoperatively. Patient 1 and Patient 2 were
advanced to regular diet on postoperative days 1 and 2,
respectively. There were no perioperative complications.
Figure 3 Sequential Ligation of (a) Main Left Renal Artery and (b) 
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At follow up of 7 and 6 months for Case 1 and 2 respec-
tively, both patients are alive without evidence of renal
fossa recurrence.
Discussion
Locally advanced RCC with renal vein thrombus has his-
torically presented a more challenging surgical case that
is most often performed via an open technique. Advances
in laparoscopy have led investigators to examine the fea-
sibility of LRN for locally advanced tumors. Recent
reports demonstrate that hand-assisted and pure laparo-
scopic nephrectomy can be safe and effective for tumors
with renal vein thrombus [9-11]. Guzzo et al reported 37
patients who underwent LRN for T3b RCC with opera-
tive outcomes comparable to LRN for lower stage tumors
[median operative time 190 minutes, median EBL 200 ml,
and median length of stay (LOS) 3 days, median patho-
logic size 7.5 cm [9]. Henderson, et al. documented onco-
logic outcomes comparable to open radical nephrectomy
for 13 patients with T3b disease that underwent hand-
assisted laparoscopic nephrectomy (HALN) [10]. With
median follow-up of 2.7 years, 3 of 12 patients developed
metastatic disease without local recurrence. Periopera-
tive outcomes were similar to Guzzo et al., with median
operative time 176 min, EBL 250 ml, and LOS 3 days.
Martin et al. reported 14 patients with mean follow-up of
32 months who underwent LRN for T3b disease with one
conversion to open due to positive frozen section in the
renal vein, and all without local recurrence 4 years later.
Two patients with high-grade RCC and extracapsular
extension developed metastatic disease. Mean operative
time was 140 minutes, EBL 155 ml, LOS 2.9 days [11].
Our pilot experience, with OR times ranging 132-171
minutes, EBL of 100 ml, and LOS 2-3 days is comparable
Table 2: Perioperative Variables and Outcomes
Variable Patient 1
(right-sided)
Patient 2
(left-sided)
OR time (min) 132 171
Number of Trocars 4 4
Incision length (cm) 5 4
EBL (ml) 100 100
Preoperative Hematocrit (%) 30.9 26.7
Postoperative Hematocrit (%) 27.7 23.5
Preoperative Creatinine (mg/dL) 0.8 0.7
Postoperative Creatinine (mg/dL) 1.2 1.0
Pathology RCC, clear cell, Grade 2, T3bNxMx, 8.0 cm RCC, clear cell, Grade 3, T3bNxM1, 7.6 cm
Length of hospital stay (days/h) 2/57 3/81
complications None None
Figure 4 Six month postoperative appearance of incision for pa-
tient 1 (right sided tumor).
 
Figure 5 Left renal mass gross specimen demonstrating the renal 
venous thrombus.
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with these reports. The issue of cosmesis is not addressed
in depth in series of LRN for T3b tumors and we are
unable to compare our incision sizes with these series.
We chose to proceed with a periumbilical approach.
Indeed, while a Pfannenstiel incision has been reported
upon for radical nephrectomy [12], nephroureterectomy
[12], and donor nephrectomy [13], we felt more comfort-
able with closer access to the renal hilum, adrenal and
upper pole. Indeed, while a Pfannenstiel approach may
offer some further advantages, we felt that upper pole
retraction (for adrenal and bulky tumor dissection) may
be more easily facilitated and the vascular dissection may
more be readily approached peri-umbilically.
Safe, complete thrombectomy is facilitated by opti-
mized exposure with meticulous dissection and identifi-
cation of a transition point at the distal thrombus margin.
Martin et al. described adding a hand-port for manual
assistance when laparoscopic milking or determination of
tumor thrombus margin was difficult [11]. In our experi-
ence, addition of a fourth trocar and insertion of a laparo-
scopic paddle assists with bowel retraction for optimal
vascular exposure. A long atraumatic bowel grasper may
aid in milking the tumor thrombus away from the IVC
and determining margin for venous ligation. On the right
side, the stapler is placed flush against the IVC and on the
left side, the stapler is placed distal to the transition point
of the thrombus.
LESS-RN is a relatively new technique, and although
initial results have been comparable to multi-site LRN
[7], a larger number of cases must be performed to estab-
lish whether LESS-RN is equivalent to multi-site LRN or
open radical nephrectomy for RCC with renal vein
thrombectomy. A small number of patients and relatively
short length of follow-up limit our experience. At this
time we would not recommend LESS-RN-RVT for
tumors crossing midline or those associated with bulky
lymphadenopathy. Furthermore, as this pilot series uti-
lized carefully selected patients, and while we believe that
application of the LESS platform to nephrectomy/throm-
bectomy is potentially more limited by the type of tumor
as opposed to the BMI of the patient, patients who are
profoundly obese would likely require a lateral shift in
port placement. The technique of LRN with concurrent
inferior vena cava (IVC) tumor thrombectomy has been
demonstrated [14]. This technique requires an additional
8 to 12 cm incision. Application of LESS technique may
be adaptable to select LRN with IVC thrombectomy by
extending the peri-umbilical midline incision made dur-
ing LESS-RN cephalad, allowing adequate exposure for
IVC thrombectomy. Lymph node dissection at the time of
nephrectomy is a controversial topic and an area of
renewed investigation. While a clear indication exists for
excision of radiologically-identified lymphadenopathy,
emerging data demonstrate that incidence of unsus-
pected lymph-node metastases is low (4.0%) and that no
established survival advantage of a complete lymph-node
dissection in conjunction with nephrectomy exists [15].
As none of our cases demonstrated lymphadenopathy,
lymphadenectomy at the time of nephrectomy was not
performed. However, LESS-lymphadenectomy at the
time of colectomy [16] and retroperitoneal lymphadenec-
tomy has been reported in the gynecological literature
[17], and we see no limitation to the accomplishing of this
in the setting of nephrectomy, depending on lymph node
location and bulk.
The main goal of cancer surgery is cure when possible.
LESS parallels many advancements made by multi-site
laparoscopy with quivalent operative outcomes to multi-
site laparoscopy having been demonstrated in select
patients. While cosmetic benefits have been demon-
strated with the LESS platform, emerging data on other
quality of life variables such as shortened length of stay
and minimal analgesic requirement have also been
reported [7,12,13,18]. Our preliminary experience is con-
sistent with these findings. One patient did not require
opiates postoperatively, the other who was on baseline
hydrocodone returned to preoperative analgesics within
23 hours; both resumed regular oral intake by 36 hours,
and patient-1 and -2 were discharged home 57 hours and
81 hours after admission, respectively. No perioperative
complications were encountered. Indeed, further reduc-
tions in recovery time and analgesic requirements may
very well help improve quality of life in patients with
advanced cancer, and in Case 2, the patient was able to
start systemic targeted therapy 2 weeks postoperatively.
However, further experience, and prospective compari-
son to multi-port laparoscopy is necessary to delineate
the optimal utilization of LESS in the minimally invasive
armamentarium.
Conclusion
Our initial experience demonstrates LESS-RN-RVT is
safe and efficacious for selected patients. Further experi-
ence and follow up are requisite to determine appropri-
ateness of LESS-RN-RVT.
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